Skip to content
Synovo
Toggle menu
  • Home
  • Services
    • Summary Services
    • Disease Models
    • Chemistry Services
    • Histology
  • Innovation
  • TeamScience
  • Career
  • News
  • Contact

Category: Orphan Drugs

1. March 201810. September 2018Orphan Drugs

#ShowYourRare

We would like to create awareness of rare diseases and the necessity of collaborating to improve the quality of life of those […]

21. October 20148. January 2018Orphan Drugs

Orphan designation for pancreatic cancer

Orphan designation for SYD003 for the treatment of pancreatic cancer. Granted by the European Medicines Agency (EMA) on 22 August 2014 and by […]

20. February 20148. January 2018Orphan Drugs

Orphan designation for treatment of CF

Our compound SYD0073 has been granted orphan designation (EU/3/14/1239) by the European Medicines Agency (EMA) for the treatment of cystic fibrosis.

Synovo GmbH
Paul-Ehrlich-Str. 15
72070 Tübingen
Germany

Synovo GmbH
Paul-Ehrlich-Str. 15
D-72076, Tübingen
Germany

T +49 (0) 7071 964325
F +49 (0) 7071 964326
contact@synovo.com

NOVIRUSES2BRAIN

Legal Notice

Datenschutzerklärung
© 2023 Synovo. Proudly powered by Sydney